Zobrazeno 1 - 10
of 434
pro vyhledávání: '"LJ Esserman"'
Autor:
Sonal Shad, William Fraser Symmans, Debu Tripathy, Lamorna Brown-Swigart, LJ Esserman, Jane Perlmutter, V. Valero, Rebekah Gould, Gregor Krings, Judy C. Boughey, Jodi M. Carter, M. van der Noordaa, Gillian L. Hirst, L.J. van 't Veer, Christina Yau, Douglas Yee, Lajos Pusztai, Tufia C. Haddad, Kathy S. Albain, Molly Klein, Lili Du, MC Liu, Rita Nanda, Claudine Isaacs, Richard Schwab, Amy Jo Chien, Donald A. Berry, Rachel M. Layman, AM DeMichele, Isabelle Bedrosian, Sara J. Venters, Nola M. Hylton
Publikováno v:
Annals of Oncology. 32:642-651
BACKGROUND We proposed that a test for sensitivity to the adjuvant endocrine therapy component of treatment for patients with stage II-III breast cancer (SET2,3) should measure transcription related to estrogen and progesterone receptors (SETER/PR in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082ef2b88b706887b4cdf6ebbaef357d
https://doi.org/10.1016/j.annonc.2021.02.011
https://doi.org/10.1016/j.annonc.2021.02.011
Autor:
AM DeMichele, Anette Weyergang, Ane Sofie Viset Fremstedal, Olav Engebråten, Kristian Berg, Øystein Garred, Christina Yau, Elin Borgen, Maria Eb Berstad, L. vant`t Veer, LJ Esserman
PURPOSETargeted therapeutics strongly depends on validated biomarkers in order to select patients most likely to benefit from the treatment. HER2 serves as a predictive biomarker for HER2-targeted tyrosine kinase inhibitors and monoclonal antibodies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19a7feab317450548381f21392cd3aaa
https://doi.org/10.1101/2021.07.06.21255069
https://doi.org/10.1101/2021.07.06.21255069
Publikováno v:
Cancer Research. 79:P1-11
Purpose/Objective(s): Symptom burden in the advanced cancer patient can be substantial. PROMIS (Patient Reported Outcome Measurement Information System) is a powerful PRO symptom assessment tool that is increasingly being utilized at the point of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ed7266b56769d9ed6a01f1362ea2488
https://doi.org/10.1158/1538-7445.sabcs18-p1-11-18
https://doi.org/10.1158/1538-7445.sabcs18-p1-11-18
Autor:
Debu Tripathy, AS Clark, AD Elias, William Fraser Symmans, Je Lang, Amy Wilson, Kirsten H. Edmiston, Christos Vaklavas, Preya Shah, L.J. van 't Veer, Melanie Catherine Majure, Denise M. Wolf, Judy C. Boughey, Amy Jo Chien, M. Melisko, Nola M. Hylton, Richard Schwab, Christina Yau, Rita Nanda, Claudine Isaacs, Barbara Haley, Teresa Helsten, Donald A. Berry, HS Han, Erin D. Ellis, Erica Stringer-Reasor, Qamar J. Khan, KS Albain, Nora Jaskowiak, Erin Roesch, S Asare, AM DeMichele, HS Rugo, Cheryl Ewing, LJ Esserman, C Lee, Tufia C. Haddad, Kathleen Kemmer, Larissa A. Korde, Anne M. Wallace, Jane Perlmutter, Ruby Singhrao, D Yee, Andres Forero, Rebecca K. Viscusi, Janice Lu, Donald W. Northfelt
Publikováno v:
Cancer Research. 79:P1-15
This abstract was withdrawn by the authors. Citation Format: Schwab R, Clark A, Yau C, Wolf D, Chien AJ, Majure M, Ewing C, Wallace A, Roesch E, Helsten T, Forero A, Stringer-Reasor E, Vaklavas C, Nanda R, Jaskowiak N, Boughey J, Haddad T, Han H, Lee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4df83f2f6923d8685d038066fe93072
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-02
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-02
Abstract P4-09-03: Simulated outcomes of personalized versus guideline-based breast cancer screening
Publikováno v:
Cancer Research. 79:P4-09
Introduction: Personalized screening, or screening tailored to individual breast cancer risk, is being studied as an improvement on the current practice of guideline-based screening. WISDOM (Women Informed to Screen Depending on Measures of Risk) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6a56e94f9a4ee1f6a4f2451d0866fb8
https://doi.org/10.1158/1538-7445.sabcs18-p4-09-03
https://doi.org/10.1158/1538-7445.sabcs18-p4-09-03
Autor:
John P. Pierce, WP Shibley, Nickolas Dreher, Stanton A. Glantz, Irene Acerbi, LJ Esserman, Anne M. Wallace, Advocate Partners, Robert A. Hiatt, Bev Parker, J Guydish, Sarah L. Blair, TM Layton, L van 't Veer
Publikováno v:
Cancer Research. 79:P4-10
Background: Smoking is a known risk factor for various types of cancer, and breast cancer patients who smoke are known to have higher breast cancer mortality. However, few studies have found an association between smoking and breast cancer incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aaf26cfa9284834a917e78f008783ab
https://doi.org/10.1158/1538-7445.sabcs18-p4-10-03
https://doi.org/10.1158/1538-7445.sabcs18-p4-10-03
Autor:
Jasmine Wong, LJ Esserman, Ava Hosseini, Holly Keane, Flora Varghese, Amal L. Khoury, Rita A. Mukhtar, SE Eder
Publikováno v:
Cancer Research. 79:P4-11
Background: Post-mastectomy pain syndrome (PMPS) is a common and often debilitating condition. One common cause likely results from injury to the T4 and T5 sensory nerves during breast surgery, with resulting neuroma formation. It manifests as a pain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa2627d7d68f8a9cba17b59ab1e4aeb5
https://doi.org/10.1158/1538-7445.sabcs18-p4-11-01
https://doi.org/10.1158/1538-7445.sabcs18-p4-11-01
Autor:
Christina Yau, Andres Forero, L van 't Veer, LJ Esserman, Heather Beckwith, Lamorna Brown-Swigart, HS Rugo, S Asare
Publikováno v:
Cancer Research. 79:P3-10
Background: LIV-1 is an estrogen-inducible gene that has been implicated in epidermal-to-mesenchymal transition (EMT) in preclinical models of progression and metastasis. Its expression is associated with node-positivity in breast cancer; and has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4445068806f2cf253efc73ad222f3a42
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-14
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-14
Autor:
Erin D. Ellis, Shelly S. Lo, William C. Wood, C Isaacs, L Korde, Kirsten K. Edmiston, Debu Tripathy, D Yee, Je Lang, Sy Chui, MC Liu, Heather Beckwith, Rita Nanda, DW Northfelt, Kathleen Kemmer, E Price, Judy C. Boughey, L Pusztai, AS Clark, A Forero-Torres, Rita A. Mukhtar, John W. Park, KS Albain, AJ Chien, L Suleiman, HS Han, Richard Schwab, O. I. Olopade, C Yau, S. L. Moulder, R Singhrao, DM Euhus, A DeMichele, S Asare, Rebecca K. Viscusi, Donald A. Berry, Anne M. Wallace, J Lu, HS Rugo, AD Elias, J Silverstein, LJ Esserman, Teresa Helsten, QJ Khan, Brian Leyland-Jones
Publikováno v:
Cancer Research. 79:P2-14
Background: In women with breast cancer receiving neoadjuvant chemotherapy, residual cancer burden (RCB) predicts distant recurrence and survival. In those with high risk tumors, locoregional recurrence (LRR) remains a concern, and has been associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::397f64652e6e8541fe7f63399a0d67be
https://doi.org/10.1158/1538-7445.sabcs18-p2-14-01
https://doi.org/10.1158/1538-7445.sabcs18-p2-14-01
Autor:
D Yee, AM DeMichele, S Lin, Marcia R. Campbell, Christina Yau, Gillian L. Hirst, P Savas, Lamorna Brown-Swigart, S Asare, Zelos Zhu, Denise M. Wolf, L van 't Veer, Deborah L. Berry, LJ Esserman, Sherene Loi
Publikováno v:
Cancer Research. 79:P3-10
Background: Expression-based signatures have been shown to predict neoadjuvant therapy response; but further studies are needed to deconvolve the contribution of different immune cell types. The I-SPY 2 TRIAL is a standing neoadjuvant platform trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9c94e140d42b925b64d8113f070479
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-06
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-06